• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A review of kala-azar in China from 1949 to 1959.

作者信息

Leng Y J

出版信息

Trans R Soc Trop Med Hyg. 1982;76(4):531-7. doi: 10.1016/0035-9203(82)90157-2.

DOI:10.1016/0035-9203(82)90157-2
PMID:6926774
Abstract

This is the first account of China as an important area of kala-azar to appear in the west for nearly 50 years. The review is divided into four main sections. The epidemiological aspects which are described include the geographical distribution and endemicity (under the sub-headings natural conditions of the epidemic area, age distribution, sex differences, seasonal changes in incidence) and research on reservoirs (under the sub-headings survey of canine leishmaniasis and survey of other wild and domestic animals). The section on clinical aspects covers symptoms and signs, post kala-azar dermal leishmaniasis, laboratory diagnosis (puncture, serum tests, complement fixation test, intradermal test) and treatment (medication and the effects of treatment). The possibility that two different types of kala-azar occur in China is discussed and the paper concludes with an appraisal of the present position.

摘要

相似文献

1
A review of kala-azar in China from 1949 to 1959.
Trans R Soc Trop Med Hyg. 1982;76(4):531-7. doi: 10.1016/0035-9203(82)90157-2.
2
Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis).比哈尔邦黑热病(包括黑热病后皮肤利什曼病)的流行病学、临床及治疗特征
Trans R Soc Trop Med Hyg. 1984;78(3):391-8. doi: 10.1016/0035-9203(84)90131-7.
3
[Epidemiological characteristics of Kala-azar disease in China, during 2005-2015].2005 - 2015年中国黑热病的流行病学特征
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Apr 10;38(4):431-434. doi: 10.3760/cma.j.issn.0254-6450.2017.04.004.
4
Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.印度比哈尔邦内脏利什曼病流行地区的黑热病后皮肤利什曼病。
Trop Med Int Health. 2012 Nov;17(11):1345-8. doi: 10.1111/j.1365-3156.2012.03067.x. Epub 2012 Aug 12.
5
[Survey on a new case of visceral leishmaniasis in Shanxi Province].[山西省一例内脏利什曼病新病例的调查]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2012 Jun 30;30(3):188-90.
6
Resurgence of visceral leishmaniasis in Bangladesh.孟加拉国内脏利什曼病的死灰复燃。
Bull World Health Organ. 1983;61(1):113-6.
7
Preliminary survey of domestic animal visceral leishmaniasis and risk factors in north-west Ethiopia.埃塞俄比亚西北部家畜内脏利什曼病及危险因素的初步调查
Trop Med Int Health. 2015 Feb;20(2):205-10. doi: 10.1111/tmi.12418. Epub 2014 Nov 20.
8
[Kala-azar in China from 1985 to 1988. Advisory Committee on Parasitic Diseases, MOPH].[1985年至1988年中国的黑热病。卫生部寄生虫病咨询委员会]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1989;7(3):161-2.
9
Kala-azar in Darfur: Evidence for indigenous transmission in Al-Malha Locality, North Darfur, western Sudan.达尔富尔的黑热病:来自苏丹西部北达尔富尔省 Al-Malha 地区本土传播的证据。
Parasit Vectors. 2018 Mar 6;11(1):149. doi: 10.1186/s13071-018-2746-3.
10
Canine leishmaniasis in Morocco with special reference to infantile kala-azar.摩洛哥的犬利什曼病,特别提及婴儿黑热病。
Trans R Soc Trop Med Hyg. 1987;81(2):212-3. doi: 10.1016/0035-9203(87)90217-3.

引用本文的文献

1
Application of improved harmonic Poisson segmented regression model in evaluating the effectiveness of Kala-Azar intervention in Yangquan City, China.改良谐波泊松分段回归模型在中国阳泉市评估黑热病干预效果中的应用。
Front Public Health. 2024 Jul 31;12:1326225. doi: 10.3389/fpubh.2024.1326225. eCollection 2024.
2
From Infection to Death: An Overview of the Pathogenesis of Visceral Leishmaniasis.从感染到死亡:内脏利什曼病发病机制概述
Pathogens. 2023 Jul 24;12(7):969. doi: 10.3390/pathogens12070969.
3
Gender disparity in cases enrolled in clinical trials of visceral leishmaniasis: A systematic review and meta-analysis.
临床试验中内脏利什曼病病例的性别差异:系统评价和荟萃分析。
PLoS Negl Trop Dis. 2021 Mar 16;15(3):e0009204. doi: 10.1371/journal.pntd.0009204. eCollection 2021 Mar.
4
Effectiveness of Short-Course Meglumine Antimoniate (Glucantime®) for Treatment of Visceral Leishmaniasis: A 13-Year, Multistage, Non-Inferiority Study in Iran.短疗程葡甲胺锑酸盐(葡糖胺锑钠®)治疗内脏利什曼病的疗效:伊朗一项为期13年的多阶段非劣效性研究。
Am J Trop Med Hyg. 2017 Jan 11;96(1):182-189. doi: 10.4269/ajtmh.16-0345. Epub 2016 Nov 22.
5
Development of a dipstick assay for detection of Leishmania-specific canine antibodies.用于检测利什曼原虫特异性犬抗体的试纸条检测法的开发。
J Clin Microbiol. 2004 Jan;42(1):193-7. doi: 10.1128/JCM.42.1.193-197.2004.
6
Use of PCR for diagnosis of post-kala-azar dermal leishmaniasis.聚合酶链反应用于诊断黑热病后皮肤利什曼病。
J Clin Microbiol. 1998 Jun;36(6):1621-4. doi: 10.1128/JCM.36.6.1621-1624.1998.
7
Pharmacokinetics of antimony in patients treated with sodium stibogluconate for cutaneous leishmaniasis.葡萄糖酸锑钠治疗皮肤利什曼病患者中锑的药代动力学
Pharm Res. 1995 Jan;12(1):113-6. doi: 10.1023/a:1016251023427.